molecules-logo

Journal Browser

Journal Browser

Analysis of Breath and Environment VOCs in Health and Disease

A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Analytical Chemistry".

Deadline for manuscript submissions: 30 June 2024 | Viewed by 164

Special Issue Editors


E-Mail Website
Guest Editor
Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital Aachen, RWTH University Aachen, 52074 Aachen, Germany
Interests: mental health; biomarkers; neuroimaging; volatile organic compounds; proteomics

E-Mail Website
Guest Editor
Medical Systems Technology, OVGU University Magdeburg, 39106 Magdeburg, Germany
Interests: medical systems; breath gas

Special Issue Information

Dear Colleagues,

Neuropsychiatric disorders are increasingly recognized as leading causes of disease burden. The WHO estimates a 25% increase in mental disorders during the COVID-19 pandemic. Moreover, behavioral adaptation is needed in view of the climate crisis, a process that further poses a risk for mental health. To date, objective markers are not available, in particular for psychiatric disorders such as depression and schizophrenia, and there is a pressing need to identify biotypes in neuropsychiatric disorders that require different therapies. Nevertheless, signatures from the metabolome and microbiome have already been introduced as candidates for diagnostic and treatment support. A marker particularly applicable for psychiatric disorders is one that can be obtained noninvasively, without much discomfort for patients, and multiple times daily, if necessary. Recent developments are the introduction of breath gas measurements using mass spectrometry to identify volatile organic compounds (VOCs), as well as the investigation of the human microbiome or proteome analysis from blood. With respect to VOCs, these measurements can also capture signatures from the environment.

In this Special Issue, we aim to collect papers that address the identification of such markers in the field of neuropsychiatric disorders including, e.g., depression, PTSD, bipolar disorders, neurodegenerative disorders and stroke.

Prof. Dr. Thomas Frodl
Prof. Dr. Christoph Hoeschen
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • breath markers
  • volatile organic compounds
  • VOCs
  • neuropsychiatric disorders
  • mental health
  • proteomics
  • biotypes
  • metabolomics

Published Papers

This special issue is now open for submission.
Back to TopTop